6 active trials 2 recruiting 1 Phase 3 8 disease areas
| Phase 1/2 | 2 | |
| Phase 2 | 3 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT03592472 | A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or… | Renal Cell Carcinoma | Recruiting | 2025-04-13 |
| Phase 2 | ||||
| NCT03936153 | Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or… | Diffuse Large B-cell Lymphoma (DLBCL) | Recruiting | 2025-04-10 |
| NCT03600441 | Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma | Follicular Lymphoma | Active, Not Recruiting | 2025-04-10 |
| NCT03934567 | A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as… | Lymphoma, Follicular | Active, Not Recruiting | 2025-04-10 |
| Phase 1/2 | ||||
| NCT04024696 | A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in… | Non Hodgkin Lymphoma | Active, Not Recruiting | 2025-04-10 |
| NCT05275374 | XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a… | Cancer | Not Yet Recruiting | 2025-04-10 |
Kidney Cancer (1) · Follicular Lymphoma (1) · DLBCL (1) · Non-Hodgkin Lymphoma (1) · Lung Cancer (1) · Colorectal Cancer (1) · Melanoma (1) · Thyroid Cancer (1)